Why is it so hard to disrupt health insurance?
I’m reeling from a critical take from short-selling specialist Hindenburg Research, which was published today on Clover Health. Clover, if you’re not familiar, is a health insurance player backed by notable investor Chamath Palihapitiya. Clover’s shares tumbled off the back of the report. I won’t delve too deeply into that, in part because Clover hasn’t yet responded to the allegations.
But I did want to take a step back and reflect on the crop of companies trying to disrupt the health plan market.
For context on that, I turned to Ari Gottlieb, principal at A2 Strategy Corp, who specializes in health insurance. Gottlieb pays close attention to the slew of venture-funded health plans, including Oscar Health, Bright Health, Clover Health and Devoted Health, including by poring over state filings. Between them, these start-ups have raised tens of billions of dollars from investors.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
Office Hours
A live Q&A with Christina Farr and Ruth Reader, exclusively for Second Opinion Premium members. Thursday, December 3, 3–4 p.m. ET / noon–1 p.m. PT.
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
The Shift Left & the Impact of the Midterms on Healthcare
Democrats just took both chambers. Aneesh Chopra, Christopher Kerns and Mike Desjadon join Ruth Reader and Christina Farr live to talk through what they'll try to do on healthcare — and what's actually achievable under a Republican White House.
Is It Finally the Moment for Alternative Health Plans?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&